Grace Therapeutics (GRCE) Intangibles (2019 - 2026)
Grace Therapeutics' Intangibles was $27.6 million in fiscal Q1 2027 (quarter ended Jun 30, 2026), down 32.9% from $41.13 million a year earlier and down 32.9% from the prior quarter.
Powered by 
Analysis
Grace Therapeutics (GRCE) Intangibles (2019 - 2026) Analysis & Trends
At the end of FY2026 (ended Mar 31, 2026), Intangibles at Grace Therapeutics came in at $41.13 million, unchanged from FY2025.
- Intangibles shows a four-year compound annual growth rate of -12.4% (FY2022 to FY2026).
- In earlier fiscal years, Intangibles was $41.13 million in FY2025 (unchanged), $41.13 million in FY2024 (unchanged), $41.13 million in FY2023 (-41.1%) and $69.81 million in FY2022.
- The fiscal Q1 2027 figure marks the lowest quarterly Intangibles since fiscal Q1 2021.
- The best year-over-year quarter for Intangibles over five years was fiscal Q3 2023 (growth of 7.1%); the worst was fiscal Q4 2023 (a decline of 41.1%).
- Per Business Quant data, GRCE's Intangibles in the three fiscal quarters before Q1 2027 was $41.13 million (Q4 2026), $41.13 million (Q3 2026) and $41.13 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 18.11 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 48.23 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 49.14 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 24.98 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 42.07 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 37.72 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 20.49 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 14.03 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 47.05 Bn |
| 10 | Grace Therapeutics | 34.02 Mn | -32.25 Mn | - | 27.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 27.60 Mn |
| Mar 31, 2026 | 41.13 Mn |
| Dec 31, 2025 | 41.13 Mn |
| Sep 30, 2025 | 41.13 Mn |
| Jun 30, 2025 | 41.13 Mn |
| Mar 31, 2025 | 41.13 Mn |
| Dec 31, 2024 | 41.13 Mn |
| Sep 30, 2024 | 41.13 Mn |
| Jun 30, 2024 | 41.13 Mn |
| Mar 31, 2024 | 41.13 Mn |
| Dec 31, 2023 | 41.13 Mn |
| Sep 30, 2023 | 41.13 Mn |
| Jun 30, 2023 | 41.13 Mn |
| Mar 31, 2023 | 41.13 Mn |
| Dec 31, 2022 | 69.81 Mn |
| Sep 30, 2022 | 69.81 Mn |
| Jun 30, 2022 | 69.81 Mn |
| Mar 31, 2022 | 69.81 Mn |
| Dec 31, 2021 | 65.21 Mn |
| Sep 30, 2021 | 65.21 Mn |
API Access
Grace Therapeutics Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=intangibles&ticker=GRCE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "intangibles", "ticker": "GRCE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=intangibles&ticker=GRCE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();